Find all of the Taylor & Francis journals relevant to you, in one place. Bookmark the Taylor & Francis Biotechnology Hubpage today!
Keep reading for free content and details of which journals would like to hear from you.
Click on the links below to see the latest issue.
Acta Biomaterialia Odontologica Scandinavica
Annals of Medicine
Artificial Cells, Nanomedicine, and Biotechnology
Biocatalysis and Biotransformation
Biotechnology and Genetic Engineering Reviews
Biotechnology and Biotechnological Equipment
Bioscience, Biotechnology and Biochemistry
British Journal of Biomedical Science
Cell Communication and Adhesion
Communicative & Integrative Biology
Critical Reviews in Biochemistry and Molecular Biology
Critical Reviews in Biotechnology
Critical Reviews in Clinical Laboratory Sciences
Critical Reviews in Microbiology
Expert Opinion on Biological Therapy
Expert Opinion on Drug Discovery
Expert Review of Medical Devices
Expert Review of Molecular Diagnostics
Expert Review of Proteomics
Human Vaccines & Immunotherapeutics
International Journal of Food Sciences and Nutrition
International Reviews of Immunology
Journal of Horticultural Science and Biotechnology
Journal of Microencapsulation
Pharmaceutical Development and Technology
Are you looking for the right journal to publish in?
The Editors of the journals listed below want to publish your research. Click on the links below to find out if one of these is right for you.
We've compiled a list of some of our most-read Biotechnology articles. Enjoy free online access to these until December 31, 2017.
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Jennifer Dumont, Don Euwart, Baisong Mei, Scott Estes & Rashmi Kshirsagar
Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer
Julia Stieglmaier, Jonathan Benjamin & Dirk Nagorsen
Unraveling the potential of CRISPR-Cas9 for gene therapy
Rodolphe Barrangou & Andrew P. May
CAR-modified T-cell therapy for cancer: an updated review
Mostafa Haji-Fatahaliha et al.
Pembrolizumab: the value of PDL1 biomarker in head and neck cancer
Raffaele Addeo, Michele Caraglia & Giada Iuliano